13-113115325-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019616.4(F7):​c.365-335T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.183 in 152,130 control chromosomes in the GnomAD database, including 3,269 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3269 hom., cov: 33)

Consequence

F7
NM_019616.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.640

Publications

8 publications found
Variant links:
Genes affected
F7 (HGNC:3544): (coagulation factor VII) This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
F7 Gene-Disease associations (from GenCC):
  • congenital factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • factor VII deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_019616.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019616.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F7
NM_019616.4
MANE Select
c.365-335T>G
intron
N/ANP_062562.1P08709-2
F7
NM_000131.5
c.431-335T>G
intron
N/ANP_000122.1
F7
NM_001267554.2
c.179-335T>G
intron
N/ANP_001254483.1F5H8B0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F7
ENST00000346342.8
TSL:1 MANE Select
c.365-335T>G
intron
N/AENSP00000329546.4P08709-2
F7
ENST00000375581.3
TSL:1
c.431-335T>G
intron
N/AENSP00000364731.3P08709-1
F7
ENST00000891255.1
c.577+258T>G
intron
N/AENSP00000561314.1

Frequencies

GnomAD3 genomes
AF:
0.182
AC:
27723
AN:
152012
Hom.:
3247
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.324
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.209
Gnomad EAS
AF:
0.0478
Gnomad SAS
AF:
0.277
Gnomad FIN
AF:
0.0767
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.122
Gnomad OTH
AF:
0.193
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.183
AC:
27789
AN:
152130
Hom.:
3269
Cov.:
33
AF XY:
0.182
AC XY:
13515
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.324
AC:
13448
AN:
41454
American (AMR)
AF:
0.150
AC:
2298
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.209
AC:
724
AN:
3472
East Asian (EAS)
AF:
0.0479
AC:
248
AN:
5176
South Asian (SAS)
AF:
0.277
AC:
1333
AN:
4816
European-Finnish (FIN)
AF:
0.0767
AC:
814
AN:
10616
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.122
AC:
8293
AN:
67990
Other (OTH)
AF:
0.191
AC:
405
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1100
2200
3299
4399
5499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
2785
Bravo
AF:
0.191
Asia WGS
AF:
0.174
AC:
605
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.9
DANN
Benign
0.28
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs493833;
hg19: chr13-113769639;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.